ID1 and cancer: Moreover, Id1Lyz-KO in TAMs abrogated the effects of ML323 treatment on cancer stemness and CD8+ T cell migration (Fig. 7o, p; Supplementary Fig. 6i, j), indicating the effect of ML323 on TAMs are mediated by Id1.